OncoDNA is a pioneering company dedicated to enhancing patient health through precision medicine. By empowering healthcare providers, biopharma companies, and researchers, OncoDNA aims to deliver personalized treatment solutions tailored to individual patient needs. The company specializes in advanced genomic testing services, providing innovative products such as the OncoDEEP® Kit for solid biopsy, the OncoSELECT® Kit for liquid biopsy, and OncoXPLORE® for tumor-naïve molecular profiling. These solutions ensure that oncology professionals can organize Next Generation Sequencing (NGS) testing effectively, leading to timely clinical interpretations that guide treatment decisions.

Additionally, OncoDNA offers clinical testing and enrollment, alongside comprehensive data intelligence services through OncoCDI®. The organization's commitment to improving patient access to precision medicine is underscored by collaborative partnerships throughout the healthcare ecosystem, aiming to streamline workflows and enhance treatment outcomes. With a wealth of experience and a focus on innovation, OncoDNA is at the forefront of the evolving landscape of oncology, transforming how cancer management and care are approached.